News & Articles

INTEGRA Biosciences, Sartorius, Waters and BMG LABTECH among those recognized during celebration of top technologies advancing life sciences

Partnership will develop conjugated FFPE IHC validated antibodies that are compatible with the GeoMx Digital Spatial Profiler

Single cell-sequencing technology will be used by Labcorp to support clinical trials and evaluate potential applications in clinical diagnostics and companion diagnostics development

Join the team heading to Atlanta, USA, to interview scientists at the forefront of cancer research and report on expertise from all sectors of the cancer research community

Immunology-focused pharma company INmune Bio is set to start first-in-man clinical trials with a promising anti-TNF compound that could revolutionize the treatment of Alzheimer’s disease and related symptoms

We take a look at some of the latest methods and technologies disrupting drug discovery and how they’re reshaping the industry

Calcium flow tracked in heart muscle fibres in real time

New publication finds highly accurate molecular diagnoses of facioscapulohumeral muscular dystrophy (FSHD), a hereditary muscle disease

Relive the biggest stories of the month and find out what’s been making waves in the SelectScience life sciences community since the turn of the year

Dr. Jim Aguanno explores the role of natriuretic peptides – NT-proBNP and BNP – in the diagnosis of heart failure

Just leave a quick lab product review today for your chance to scoop the $100 Grand Prize this week

Stream Bio launches new range of Streptavidin-linked CPNs

In this SelectScience special feature dedicated to protein biology, discover methods to improve your experiments

New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission

Dr. Masato Nakagawa to discuss induced pluripotent stem cells for regenerative research

Five color, high-performance immunohistochemistry multiplexing solution to advance biomarker studies

Team heading to San Diego, USA, to interview leading neuroscientists and report on the newest technologies

AMSBIO announces the launch of a new range of circulating tumor DNA (ctDNA) reference standards for cancer disease management research

Research shows adding Abbott's High Sensitive Troponin-I diagnostic test to doctors' existing standard of care can help more accurately determine a person's chances of a heart attack or other cardiac event potentially months to years in advance

Citrullinated histone 3 found to be associated with increased risk of thrombosis and inflammation

Learn about the different approaches that scientists are taking towards precision medicine

We bring you insights, tips and knowledge from 11 experts as they tackle biomarker research using diverse methods